Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2008 2
2010 3
2011 5
2012 3
2013 2
2014 2
2015 3
2016 5
2017 5
2018 6
2019 3
2020 11
2021 26
Text availability
Article attribute
Article type
Publication date

Search Results

69 results
Results by year
Filters applied: . Clear all
Page 1
TWEAK/Fn14 signalling promotes cholangiocarcinoma niche formation and progression.
Dwyer BJ, Jarman EJ, Gogoi-Tiwari J, Ferreira-Gonzalez S, Boulter L, Guest RV, Kendall TJ, Kurian D, Kilpatrick AM, Robson AJ, O'Duibhir E, Man TY, Campana L, Starkey Lewis PJ, Wigmore SJ, Olynyk JK, Ramm GA, Tirnitz-Parker JEE, Forbes SJ. Dwyer BJ, et al. Among authors: robson aj. J Hepatol. 2021 Apr;74(4):860-872. doi: 10.1016/j.jhep.2020.11.018. Epub 2020 Nov 19. J Hepatol. 2021. PMID: 33221352 Free article.
Trimetazidine not beneficial after PCI.
Robson A. Robson A. Nat Rev Cardiol. 2020 Nov;17(11):679. doi: 10.1038/s41569-020-00452-w. Nat Rev Cardiol. 2020. PMID: 32918046 No abstract available.
Low-dose edoxaban in elderly patients with AF.
Robson A. Robson A. Nat Rev Cardiol. 2020 Nov;17(11):680. doi: 10.1038/s41569-020-00449-5. Nat Rev Cardiol. 2020. PMID: 32913310 No abstract available.
Hydralazine reduces myocardial infarct size.
Robson A. Robson A. Nat Rev Cardiol. 2021 Apr;18(4):232. doi: 10.1038/s41569-021-00514-7. Nat Rev Cardiol. 2021. PMID: 33462420 No abstract available.
69 results